SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-123764
Filing Date
2021-04-21
Accepted
2021-04-21 09:08:59
Documents
4
Period of Report
2021-04-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d149444d8k.htm 8-K 22735
2 EX-3.1 d149444dex31.htm EX-3.1 70820
3 EX-3.2 d149444dex32.htm EX-3.2 181433
4 EX-99.1 d149444dex991.htm EX-99.1 4857
  Complete submission text file 0001193125-21-123764.txt   281156
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 21839699
SIC: 2836 Biological Products, (No Diagnostic Substances)